Search

Your search keyword '"Deri, Norma"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Deri, Norma" Remove constraint Author: "Deri, Norma" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
39 results on '"Deri, Norma"'

Search Results

1. Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings

2. Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina

3. Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study

4. Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry

5. Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina

6. Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina

7. Guía de práctica clínica: tratamiento agudo de las enfermedades inflamatorio-desmielinizantes del sistema nervioso central: esclerosis múltiple, espectro de la neuromielitis óptica, encefalomielitis diseminada aguda, enfermedades asociadas a anticuerpos antiglicoproteína de la membrana del oligodendrocito, mielitis aguda y neuritis óptica. Elaborada por el Grupo de Trabajo de Enfermedades Desmielinizantes. Sociedad Neurológica Argentina

8. Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM

9. Guía de práctica clínica: tratamiento sintomático de esclerosis múltiple. Grupo de Trabajo de Enfermedades Desmielinizantes. Sociedad Neurológica Argentina

10. Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from Argentina

11. Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina

12. Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?

13. Aggressive multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM

14. COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM

15. What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)

16. Usage trend of oral drugs for multiple sclerosis patients in Argentina

18. Guías de práctica para indicación y contraindicaciones de vacunación de pacientes con esclerosis múltiple

19. Do immunosuppressive treatments influence immune responses against adenovirusbased COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study.

20. Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.

21. Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentina

22. Consensus recommendations on the management of multiple sclerosis patients in Argentina

24. Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM)

25. The Argentinean multiple sclerosis registry (RelevarEM): Methodological aspects and directions

26. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

27. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

28. Bases racionales de prescripción para médicos neurólogos

29. Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.

30. SEROLOGICAL RESPONSE TO SARS-COV-2 VACCINES IN PATIENTS WITH MULTIPLE SCLEROSIS IN ARGENTINA.

31. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent

32. Preferences for Disease-Modifying Therapies in Argentina: Cross-Sectional Conjoint Analysis of Patients and Neurologists.

33. Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM).

34. Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in Argentina.

35. Family planning in Argentinian women with multiple sclerosis: An important yet seldom approached issue.

36. Clinical characterization of long-term multiple sclerosis (COLuMbus) patients in Argentina: A cross-sectional non-interventional study.

37. ENCOMS: Argentinian survey in cost of illness and unmet needs in multiple sclerosis.

38. COVID-19 in Argentine teriflunomide-treated multiple sclerosis patients: First national case series.

39. Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis: Multicenter study in Argentina.

Catalog

Books, media, physical & digital resources